Target intelligence / Profile preview

Conjugated bile acids (CBA)

Target
CBA
Molecular classification
Steroid derivative, Lipid, Metabolite
01

Overview

Conjugated bile acids are steroid-based molecules synthesized from cholesterol in the liver and subsequently linked to glycine or taurine to enhance their water solubility and surfactant properties (StatPearls, 2023). Their primary biological role is the emulsification of dietary fats and the facilitation of fat-soluble vitamin absorption within the small intestine (NIH, 2022). Beyond their digestive functions, conjugated bile acids serve as critical signaling ligands for receptors such as the Farnesoid X Receptor (FXR) and the G protein-coupled bile acid receptor (TGR5), influencing systemic lipid and glucose metabolism (Nature Reviews Gastroenterology & Hepatology, 2017). Pathological accumulation or malabsorption of these acids is linked to conditions like cholestasis, bile acid diarrhea, and hypercholesterolemia. Pharmacological intervention often involves the use of bile acid sequestrants, which physically bind these acids in the gastrointestinal tract to prevent their reabsorption, thereby lowering LDL cholesterol and alleviating symptoms of bile acid-mediated pruritus (FDA, 2021).

Other names
Bile saltsGlycine-conjugated bile acidsTaurine-conjugated bile acidsGlycoconjugates of bile acidsTauroconjugates of bile acids
02

Mechanism of action

Bile acid sequestration in the gastrointestinal tract to prevent enterohepatic recirculation and promote fecal excretion.

03

Biological functions

Signal transductionLipid emulsificationCholesterol homeostasisFat-soluble vitamin absorptionMetabolic regulation
04

Disease associations

Cardiovascular diseaseInflammationBile acid malabsorptionCholestasisPrimary biliary cholangitis
05

Safety considerations

Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distress (constipation, bloating)Interference with the absorption of co-administered medications
06

Interacting drugs

Cholestyramine

2 more in the full profile.

07

Biomarkers

Total serum bile acids7α-hydroxy-4-cholesten-3-one (C4)Fecal bile acid excretionFibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Conjugated bile acids (CBA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conjugated bile acids (CBA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call